Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
2.670
+0.070 (2.69%)
At close: Apr 2, 2025, 4:00 PM
2.510
-0.160 (-5.99%)
After-hours: Apr 2, 2025, 7:12 PM EDT

Revelation Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
24346793
Market Cap Growth
22.18%22.18%-29.48%-93.31%-28.42%-
Enterprise Value
-4-3-11-270-
Last Close Price
2.607.38240.343193.69171360.32168840.31
PB Ratio
0.290.820.474.25-671.8727.37
P/TBV Ratio
0.820.820.474.25-31.04
Debt / Equity Ratio
-----0.17-
Quick Ratio
3.403.402.151.180.603.72
Current Ratio
3.433.432.181.220.893.82
Return on Equity (ROE)
-264.85%-264.85%-3.12%-2272.77%-723.81%-
Return on Assets (ROA)
-52.93%-52.93%-61.08%-179.98%-224.21%-
Return on Capital (ROIC)
-87.78%-87.78%-140.53%-1400.45%-448.74%-
Earnings Yield
-638.96%-390.37%-3.81%-242.21%-17.94%-4.06%
FCF Yield
-779.25%-476.09%-231.09%-250.93%-16.79%-2.28%
Buyback Yield / Dilution
-1103.92%-1103.92%----
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q